| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |